ACD labs

What ACD labs does

ACD/Labs (Advanced Chemistry Development, Inc.) develops and commercializes informatics software for chemical, biochemical, and pharmaceutical R&D. Founded in 1994 and headquartered in Toronto, Canada, the company built its portfolio over 30+ years around two flagship platforms: the Spectrus Platform for vendor-agnostic analytical data processing and knowledge management across LC/MS, NMR, GC/MS, HPLC, Raman, IR, and other techniques with native support for over 150 instrument data formats, and the Percepta Platform for in silico prediction of physicochemical, ADME, and toxicity properties built on 25+ years of curated experimental training data. Specialized modules address CMC decision support (Luminata), high-throughput experimentation (Katalyst D2D), metabolite identification (MetaSense), computer-assisted structure elucidation (Structure Elucidator Suite), NMR and MS processing, chromatography method development, and IUPAC nomenclature generation in 22 languages. Standalone products ChemSketch (over 2.5 million downloads) and ACD/Name extend reach to individual scientists and academic users.

The company monetizes through a hybrid model combining subscription and perpetual software licenses (e.g., ChemSketch at $320/year, ACD/Name at $475/year for self-serve), annual maintenance contracts, enterprise site-wide deployments via direct sales, and fee-based professional services for custom automation and digital transformation projects. Distribution is multi-channel: direct enterprise sales with consultation and demo requests, online e-commerce for self-serve purchasing, academic licensing with discounted pricing, and technology/integration partnerships with all major instrument vendors (Agilent, Thermo Fisher, Waters, Bruker, SCIEX, Shimadzu, PerkinElmer, JEOL), informatics platforms (Dassault BIOVIA, Schrödinger, Simulations Plus, Dotmatics, IDBS), and standards bodies (Allotrope Foundation, IUPAC, Pistoia Alliance). Customer concentration spans pharmaceutical/biotech R&D (primary), academic institutions, chemicals and materials science, flavors and fragrances, agrochemicals, forensics, environmental testing, food and beverage, and consumer goods, with 100% of the top 25 global pharma/biopharma and 18 of the top 20 universities using ACD/Labs software.

In November 2025, Revvity Inc. announced its intent to acquire ACD/Labs, and the transaction closed in mid-January 2026, integrating the company into Revvity Signals. Post-acquisition, ACD/Labs operates as part of Revvity Signals with bi-directional integration to the Revvity Signals Notebook ELN, expanded distribution through Revvity's enterprise sales force, and continued product investment including Version 2025 software releases that introduced AI-augmented reaction space exploration in Katalyst D2D and Japanese language IUPAC naming support.

Name

ACD labs

Legal name

Advanced Chemistry Development, Inc.

Website

https://acdlabs.com

Company type

Private

Founded year

1994

Operating status

Acquired

Headcount range

51–100 employees

Short description

ACD/Labs develops scientific software for chemical, biochemical, and pharmaceutical R&D, offering vendor-agnostic analytical data management and in silico molecular property prediction platforms (Spectrus, Percepta) plus standalone tools like ChemSketch and ACD/Name. The company serves 100% of the top 25 global pharma companies and 18 of 20 top universities, and was acquired by Revvity Signals in January 2026.

Ownership category

akta.pro rank

Product category

Chemistry Informatics Software

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industries

Method Development & Validation (ICH/USP) (HLAGADAB), Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)

Keywords

• Analytical chemistry software
• Molecular property prediction
• Scientific informatics software
• Chemical structure drawing
• Pharmaceutical R&D software

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Software Licenses: ACD/Labs generates revenue primarily through software licensing with both perpetual and subscription models. Customers can purchase software licenses with maintenance included or subscribe annually. Enterprise deployment options for site-wide licensing are available.
2. Software Maintenance: Annual maintenance plans provide product enhancements, bug fixes, software updates, and access to technical support specialists. Maintenance is renewable annually.
3. Professional Services: Custom consultation, digital transformation project support, and enterprise-wide automation solutions for analytical data management. Subject matter experts work with organizations to build bespoke solutions.
4. Chemical Nomenclature Service: Fee-based expert service for generating IUPAC names for submitted chemical structures and name-to-structure requests.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels9 records

Core offering

ACD/Labs develops and commercializes informatics software for chemical, biochemical, and pharmaceutical R&D. Its Spectrus Platform handles vendor-agnostic, multi-technique analytical data (LC/MS, NMR, GC/MS, HPLC, Raman, IR), while the Percepta Platform delivers in silico predictions of physicochemical, ADME, and toxicity properties. Standalone tools include ChemSketch for chemical structure drawing and ACD/Name for IUPAC nomenclature generation in 22 languages.

Product overview

ACD/Labs offers scientific software for R&D across two main platforms. The Spectrus Platform provides standardized analytical data processing and knowledge management, supporting multi-technique data (LC/MS, NMR, GC/MS, chromatography, Raman, IR) with vendor-neutral support for over 150 data formats. Key applications include Luminata for CMC decision support, Katalyst D2D for high-throughput experimentation, and MetaSense for metabolite identification. Specialized modules handle NMR (NMR Workbook Suite, NMR Predictors), MS (MS Workbook Suite, MS Structure ID Suite, MS Fragmenter), chromatography (AutoChrom, Method Selection Suite), and structure elucidation (Structure Elucidator Suite). The Percepta Platform delivers molecular property prediction through the PhysChem Suite (logP, logD, pKa), ADME Suite (absorption, distribution, metabolism), and Tox Suite (toxicity endpoints). Standalone tools include ChemSketch for structure drawing (over 2.5 million downloads) and ACD/Name for IUPAC nomenclature. The portfolio serves pharmaceutical, biochemical, and chemical industries with enterprise automation, in silico predictions, and data-driven decision support.

Differentiator

Problem solved

Functional benefit

Brands

• Spectrus Platform: Enterprise platform for standardized analytical data processing and knowledge management
• Percepta Platform
• ChemSketch
• Name

Products and services

• Spectrus Platform
• Percepta Platform
• ChemSketch
• ACD/Name
• Katalyst D2D
• Luminata
• MetaSense
• Structure Elucidator Suite

Quantifiable outcome

• Reduced data analysis cycle time from more than a week to less than a day
• +3 more outcomes

Named customers8 records

Segments11 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability6 records

Feature11 records

Partnerships

Eleven partnerships are on record, tiered core.

• Revvity SignalscoreStrategic or Co-development Partner · 1 January 2026ACD/Labs was acquired by Revvity Signals in January 2026 to expand Revvity's Signals software capabilities and enhance research informatics offerings. The acquisition integrates ACD/Labs' analytical and molecular design tools into Revvity's platform for pharmaceutical and material sciences workflows.
• AgilentcoreTechnology or IntegrationEquipment and instrument manufacturer partnership for data format support and integration with Spectrus Platform.
• Thermo Fisher ScientificcoreTechnology or IntegrationEquipment and instrument manufacturer partnership for data format support including Xcalibur, Chromeleon, and Atlas formats.
• WaterscoreTechnology or IntegrationEquipment and instrument manufacturer partnership for Empower, MassLynx, and UNIFI data format support.
• BrukercoreTechnology or IntegrationEquipment and instrument manufacturer partnership for Compass and NMR data format support.
• SCIEXcoreTechnology or IntegrationEquipment and instrument manufacturer partnership for Analyst data format support for LC/MS workflows.
• ShimadzucoreTechnology or IntegrationEquipment and instrument manufacturer partnership for LabSolutions CDS and LCMS data format support.
• PerkinElmercoreTechnology or IntegrationEquipment and instrument manufacturer partnership for TotalChrom and TOFData format support.
• JEOLcoreTechnology or IntegrationEquipment and instrument manufacturer partnership for NMR and MS data format support.
• Allotrope FoundationcoreTechnology or IntegrationStandards organization partnership for Allotrope Framework data standard support. ACD/Labs is a member of Allotrope Partner Network.
• IUPACcoreTechnology or IntegrationStandards organization partnership for JCAMP data format and nomenclature rule implementation.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Simulations Plus: Simulations Plus provides ADME-Tox modeling and physiologically-based pharmacokinetic (PBPK) simulation software. ACD/Labs is an explicit integration partner for ADME-Tox modeling, and the companies directly overlap in predicted ADME/Tox endpoints for pharma R&D.
• IDBS: IDBS delivers cloud and on-premise R&D informatics including the BioBook ELN referenced as an ACD/Labs integration partner. Comparable as a life-sciences-focused informatics platform serving pharma R&D with structured experimental data capture and workflow tools.
• Dotmatics: Dotmatics provides a scientific R&D informatics platform spanning ELN, LIMS, data management, and registration. ACD/Labs already integrates with the Dotmatics Registration Data Hub via Open Database Connectivity, indicating direct overlap in pharma/biopharma analytical data and registration workflows.
• OpenEye Scientific (Cadence Molecular Sciences): OpenEye/Cadence Molecular Sciences delivers molecular property prediction, cheminformatics, and structure-based design tools for pharma R&D. Directly comparable to ACD/Labs' Percepta Platform in molecular property and ADME prediction from chemical structure.
• ChemAxon: ChemAxon offers chemistry-focused informatics including structure drawing, nomenclature, and chemical intelligence toolkits. Directly comparable to ACD/Labs' ChemSketch and ACD/Name offerings in chemical structure handling and IUPAC naming.
• Schrödinger: Schrödinger provides computational chemistry and molecular simulation software for drug discovery. ACD/Labs lists Schrödinger as a computational chemistry integration partner, indicating overlap in molecular property prediction and drug discovery workflows targeting pharma/biotech R&D.

Others

• TIBCO Spotfire: Spotfire provides analytics and data visualization software used widely in pharma R&D. ACD/Labs integrates with Spotfire for viewing Katalyst, Luminata, and MetaSense data, positioning Spotfire as an adjacent analytics consumer rather than direct competition.

Emerging players

• Certara: Certara provides model-informed drug development software including PBPK, QSP, and regulatory submission tooling. Partial overlap with ACD/Labs' regulatory enablement and ADME prediction use cases, though Certara focuses on clinical/regulatory translation rather than analytical chemistry.

Broad incumbents

• Revvity Signals: Revvity Signals (the new parent of ACD/Labs) provides broader lab informatics and Signals software suite for pharma and material sciences. Now the parent company, but functions as the broader incumbent whose platform ACD/Labs' analytical tools are being integrated into.
• Dassault Systèmes BIOVIA: BIOVIA provides broad scientific informatics including computational chemistry, ELN, LIMS, and predictive sciences. ACD/Labs already partners with BIOVIA for DRAW file format compatibility. Overlaps with ACD/Labs in molecular property prediction and analytical data, but operates at much larger scale with a broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/ACDLabs
• YouTubeyoutube.com/user/ACDLabs
• Facebookfacebook.com/ACDLabs
• LinkedInlinkedin.com/company/acd-labs
• Instagraminstagram.com/acdlabs

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACD labs